158 related articles for article (PubMed ID: 34969682)
1. Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia.
Arambepola R; Yang Y; Hutchinson K; Mwansa FD; Doherty JA; Bwalya F; Ndubani P; Musukwa G; Moss WJ; Wesolowski A; Mutembo S
BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34969682
[TBL] [Abstract][Full Text] [Related]
2. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT
Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476
[TBL] [Abstract][Full Text] [Related]
3. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
[TBL] [Abstract][Full Text] [Related]
4. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
[TBL] [Abstract][Full Text] [Related]
5. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
[TBL] [Abstract][Full Text] [Related]
6. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
Thangaraj JWV; Prosperi C; Kumar MS; Hasan AZ; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sarmah NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murherkar MV
PLoS One; 2024; 19(3):e0297385. PubMed ID: 38551928
[TBL] [Abstract][Full Text] [Related]
7. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
[TBL] [Abstract][Full Text] [Related]
8. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
Danovaro-Holliday MC; Rhoda DA; Lacoul M; Prier ML; Gautam JS; Pokhrel TN; Dixit SM; Rajbhandari RM; Bose AS
BMC Public Health; 2022 Feb; 22(1):221. PubMed ID: 35114969
[TBL] [Abstract][Full Text] [Related]
9. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
10. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
Newtonraj A; Vincent A; Selvaraj K; Manikandan M
Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
[TBL] [Abstract][Full Text] [Related]
11. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
Ismail A; Tabu C; Onuekwusi I; Otieno SK; Ademba P; Kamau P; Koki B; Ngatia A; Wainaina A; Davis R
Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151
[TBL] [Abstract][Full Text] [Related]
12. Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys.
Utazi CE; Wagai J; Pannell O; Cutts FT; Rhoda DA; Ferrari MJ; Dieng B; Oteri J; Danovaro-Holliday MC; Adeniran A; Tatem AJ
Vaccine; 2020 Mar; 38(14):3062-3071. PubMed ID: 32122718
[TBL] [Abstract][Full Text] [Related]
13. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
[TBL] [Abstract][Full Text] [Related]
14. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
[TBL] [Abstract][Full Text] [Related]
15. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
Mutembo S; Carcelen A; Mwansa FD; Searle K; Wanyiri JW; Book C; Thuma PE; Moss WJ; Hayford K
Am J Trop Med Hyg; 2018 Dec; 99(6):1639-1642. PubMed ID: 30277204
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
[TBL] [Abstract][Full Text] [Related]
17. Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school.
Jiles RB; Fuchs C; Klevens RM
MMWR CDC Surveill Summ; 2000 Sep; 49(9):27-38. PubMed ID: 11016876
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
Mkopi A; Mtenga S; Festo C; Mhalu G; Shabani J; Tillya R; Masemo A; Kheir K; Nassor M; Mwengee W; Lyimo D; Masanja H
Vaccine; 2021 Oct; 39(41):6041-6049. PubMed ID: 34531077
[TBL] [Abstract][Full Text] [Related]
19. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005-2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era.
Mazaba ML; Siziya S; Monze M; Cohen D
BMC Infect Dis; 2020 Feb; 20(1):101. PubMed ID: 32013873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]